The Current Ratio as of November 2024 (TTM) for Phio Pharmaceuticals Corp. (PHIO) is 6.38

According to Phio Pharmaceuticals Corp.’s latest financial reports and current stock price. The company's current Current Ratio is 6.38. This represents a change of 21.29% compared to the average of 5.26 of the last 4 quarters.

Phio Pharmaceuticals Corp. (PHIO) Historical Current Ratio (quarterly & annually)

How has PHIO Current Ratio performed in the past?

The mean historical Current Ratio of Phio Pharmaceuticals Corp. over the last ten years is 5.86. The current 6.38 Current Ratio has changed 10.80% with respect to the historical average. Over the past ten years (40 quarters), PHIO's Current Ratio was at its highest in in the March 2021 quarter at 15.21. The Current Ratio was at its lowest in in the March 2018 quarter at 1.13.

Phio Pharmaceuticals Corp. (PHIO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Phio Pharmaceuticals Corp. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Phio Pharmaceuticals Corp. (PHIO) Average Current Ratio

How has PHIO Current Ratio performed in the past?

The current Current Ratio of Phio Pharmaceuticals Corp. (PHIO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Phio Pharmaceuticals Corp. (PHIO) Current Ratio vs. Peers

How is PHIO’s Current Ratio compared to its peers?

Phio Pharmaceuticals Corp.’s Current Ratio is less than Zura Bio Limited (10.36), greater than Apexigen, Inc. (1.29), greater than eFFECTOR Therapeutics, Inc. (1.03), greater than Immix Biopharma, Inc. (3.47), greater than CNS Pharmaceuticals, Inc. (1.82), greater than ZyVersa Therapeutics, Inc. (0.03), less than VectivBio Holding AG (9.14), less than AVROBIO, Inc. (26.17), less than CohBar, Inc. (15.69), greater than Ocean Biomedical, Inc. (0.03), less than Elevation Oncology, Inc. (17.77), greater than Sonnet BioTherapeutics Holdings, Inc. (1.65), greater than 180 Life Sciences Corp. (0.19), less than Cardio Diagnostics Holdings, Inc. (8.51),

Build a custom stock screener for Phio Pharmaceuticals Corp. (PHIO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Phio Pharmaceuticals Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Phio Pharmaceuticals Corp. (PHIO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Phio Pharmaceuticals Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.